New York Times runs an article on VC interest in psychedelic medicines, including psilocybin Post published:March 6, 2020 Post category:News
YIELD GROWTH Subsidiary Flourish Mushroom Labs Files for U.S. Patent to use Serotonin Agonists from Psychedelic Mushrooms for Weight Loss Post published:December 10, 2019 Post category:Press Release
CB Therapeutics Achieves Major Breakthrough in the Biosynthesis of Psilocybin, Psilocin and Related Tryptamine-based Compounds Post published:December 4, 2019 Post category:Press Release